GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OTCPK:NVZMY) » Definitions » Cyclically Adjusted Price-to-FCF

Novonesis AS (Novonesis AS) Cyclically Adjusted Price-to-FCF : 39.27 (As of Apr. 27, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Novonesis AS Cyclically Adjusted Price-to-FCF?

As of today (2024-04-27), Novonesis AS's current share price is $55.76. Novonesis AS's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $1.42. Novonesis AS's Cyclically Adjusted Price-to-FCF for today is 39.27.

The historical rank and industry rank for Novonesis AS's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

NVZMY' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 29.13   Med: 44.84   Max: 59.76
Current: 40.28

During the past years, Novonesis AS's highest Cyclically Adjusted Price-to-FCF was 59.76. The lowest was 29.13. And the median was 44.84.

NVZMY's Cyclically Adjusted Price-to-FCF is ranked worse than
64.79% of 568 companies
in the Chemicals industry
Industry Median: 23.915 vs NVZMY: 40.28

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Novonesis AS's adjusted free cash flow per share data for the three months ended in Dec. 2023 was $0.272. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $1.42 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Novonesis AS Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Novonesis AS's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS Cyclically Adjusted Price-to-FCF Chart

Novonesis AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.74 41.35 60.61 37.19 38.62

Novonesis AS Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.19 36.91 33.72 29.36 38.62

Competitive Comparison of Novonesis AS's Cyclically Adjusted Price-to-FCF

For the Specialty Chemicals subindustry, Novonesis AS's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis AS's Cyclically Adjusted Price-to-FCF Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis AS's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Novonesis AS's Cyclically Adjusted Price-to-FCF falls into.



Novonesis AS Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Novonesis AS's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=55.76/1.42
=39.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novonesis AS's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Novonesis AS's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.272/116.7000*116.7000
=0.272

Current CPI (Dec. 2023) = 116.7000.

Novonesis AS Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 1.055 99.600 1.236
201406 0.684 99.700 0.801
201409 0.497 99.700 0.582
201412 -0.052 99.400 -0.061
201503 0.284 100.200 0.331
201506 0.485 100.300 0.564
201509 0.198 100.200 0.231
201512 0.139 99.800 0.163
201603 0.306 100.200 0.356
201606 0.352 100.600 0.408
201609 0.432 100.200 0.503
201612 0.198 100.300 0.230
201703 0.348 101.200 0.401
201706 0.294 101.200 0.339
201709 0.425 101.800 0.487
201712 0.151 101.300 0.174
201803 0.225 101.700 0.258
201806 0.260 102.300 0.297
201809 0.584 102.400 0.666
201812 0.163 102.100 0.186
201903 0.220 102.900 0.250
201906 0.418 102.900 0.474
201909 0.430 102.900 0.488
201912 0.079 102.900 0.090
202003 0.430 103.300 0.486
202006 0.655 103.200 0.741
202009 0.373 103.500 0.421
202012 0.409 103.400 0.462
202103 0.401 104.300 0.449
202106 0.659 105.000 0.732
202109 0.499 105.800 0.550
202112 0.052 106.600 0.057
202203 0.204 109.900 0.217
202206 0.296 113.600 0.304
202209 0.222 116.400 0.223
202212 -0.162 115.900 -0.163
202303 -0.059 117.300 -0.059
202306 0.304 116.400 0.305
202309 0.573 117.400 0.570
202312 0.272 116.700 0.272

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Novonesis AS  (OTCPK:NVZMY) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Novonesis AS Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Novonesis AS's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis AS (Novonesis AS) Business Description

Industry
Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (Novonesis AS) Headlines

From GuruFocus

Not Just Yogurt Anymore

By PRNewswire 10-26-2023

Novozymes A/S's Dividend Analysis

By GuruFocus Research 10-19-2023

2 Holdings to Reduce Based on Analyst Recommendations

By Alberto Abaterusso Alberto Abaterusso 11-06-2019